0001415889-22-000850.txt : 20220128 0001415889-22-000850.hdr.sgml : 20220128 20220128163136 ACCESSION NUMBER: 0001415889-22-000850 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220126 FILED AS OF DATE: 20220128 DATE AS OF CHANGE: 20220128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fernandes Peter CENTRAL INDEX KEY: 0001642618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 22569317 MAIL ADDRESS: STREET 1: PERRYVILLE III CORPORATE PARK STREET 2: 53 FRONTAGE ROAD, SUITE 301 CITY: HAMPTON STATE: NJ ZIP: 08827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 form4-01282022_040125.xml X0306 4 2022-01-26 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001642618 Fernandes Peter 184 LIBERTY CORNER RD. SUITE 302 WARREN NJ 07059 false true false false CHIEF REGULATORY & SAFETY OFFR Restricted Stock Units 0 2022-01-26 4 A 0 65000 0 A Common Stock 65000 65000 D Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock. The restricted stock units are scheduled to vest 50% on December 9, 2022 and 50% on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date. Not applicable. /s/ Peter Fernandes 2022-01-28